PMID- 27330334 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20160622 LR - 20201001 IS - 1179-5514 (Print) IS - 1179-5514 (Electronic) IS - 1179-5514 (Linking) VI - 9 DP - 2016 TI - Reported Benefits of Insulin Therapy for Better Glycemic Control in Type 2 Diabetic Patients-Is This Applicable in Saudi Patients? PG - 13-7 LID - 10.4137/CMED.S38077 [doi] AB - AIM: To compare the effect of different treatment regimens (oral hypoglycemic agents [OHGs], insulin therapy, and combination of both) on glycemic control and other cardiometabolic risk factors in type 2 diabetes mellitus (T2DM) patients in Saudi. SUBJECTS AND METHODS: Patients with T2DM, but no serious diabetic complications, were randomly recruited from the diabetes clinics at two large hospitals in Jeddah, Saudi Arabia, during June 2013 to July 2014. Only those without change in treatment modality for the last 18 months were included. Blood pressure and anthropometric measurements were measured. Treatment plan was recorded from the patients' files. Fasting blood sample was obtained to measure glucose, HbA1c, and lipid profile. RESULTS: A total of 197 patients were recruited; 41.1% were men and 58.9% were women. The mean (+/-SD) age was 58.5 +/- 10.5 years. Most patients (60.7%) were on OHGs, 11.5% on insulin therapy, and 27.7% were using a combination of insulin and OHGs. The mean HbA1c was lower in patients using OHGs only, compared with means in those using insulin, or combined therapy in patients with disease duration of